View Item 

Show simple item record

Safety of leukoreduced, cytomegalovirus (CMV)‐untested components in CMV‐negative allogeneic human progenitor cell transplant recipients
dc.contributor.authorNash, Tammonen_US
dc.contributor.authorHoffmann, Sandraen_US
dc.contributor.authorButch, Suzanneen_US
dc.contributor.authorDavenport, Robertsonen_US
dc.contributor.authorCooling, Lauraen_US
dc.date.accessioned2012-11-07T17:04:34Z
dc.date.available2013-11-15T16:44:23Zen_US
dc.date.issued2012-10en_US
dc.identifier.citationNash, Tammon; Hoffmann, Sandra; Butch, Suzanne; Davenport, Robertson; Cooling, Laura (2012). "Safety of leukoreduced, cytomegalovirus (CMV)‐untested components in CMV‐negative allogeneic human progenitor cell transplant recipients." Transfusion 52(10). <http://hdl.handle.net/2027.42/94256>en_US
dc.identifier.issn0041-1132en_US
dc.identifier.issn1537-2995en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/94256
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherBlackwell Publishing Incen_US
dc.titleSafety of leukoreduced, cytomegalovirus (CMV)‐untested components in CMV‐negative allogeneic human progenitor cell transplant recipientsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationume‐mail: lcooling@med.umich.edu , Department of Pathology, University of Michigan, Ann Arbor, MIen_US
dc.contributor.affiliationotherMichigan Blood, Grand Rapids, MIen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/94256/1/j.1537-2995.2012.03739.x.pdf
dc.identifier.doi10.1111/j.1537-2995.2012.03739.xen_US
dc.identifier.sourceTransfusionen_US
dc.identifier.citedreferenceZiemann M, Krueger S, Maier AB, Unmack A, Goerg S, Hennig H. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion. Transfusion 2007; 47: 1972 ‐ 83.en_US
dc.identifier.citedreferenceBowden RA, Slichter SJ, Sayers M, Weisdorf D, Cays M, Schoch G, Banaji M, Haake R, Welk K, Fisher L, McCullough J, Miller W. A comparison of filtered leukocyte‐reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion‐associated CMV infection after marrow transplant. Blood 1995; 86: 3598 ‐ 603.en_US
dc.identifier.citedreferenceSmith D, Lu Q, Yuan S, Goldfinger D, Fernando LP, Ziman EA. Survey of current practice for prevention of transfusion‐transmitted cytomegalovirus in the United States: leucoreduction vs. cytomegalovirus‐seronegative. Vox Sang 2010; 98: 29 ‐ 36.en_US
dc.identifier.citedreferenceThiele T, Kruger W, Zimmermann K, Ittermann T, Wessel A, Steinmetz I, Kolken G, Greinacher A. Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single‐center prospective study in high‐risk patients undergoing allogeneic hematopoietic stem cell transplantation. Transfusion 2011; 51: 2620 ‐ 6.en_US
dc.identifier.citedreferenceHoffmann S, Herrst M, Butch S, Cooling L. Prestorage leukocyte‐reduced, CMV untested blood components are safe for use in CMV negative allogeneic bone marrow transplant recipients [abstract]. Transfusion 2007; 47: 212 ‐ 3.en_US
dc.identifier.citedreferenceWu Y, Zou S, Cable R, Korsey K, Tang Y, Hapip CA, Melmed R, Trouern‐Trend J, Wang JH, Champion M, Fang C, Dodd R. Direct assessment of cytomegalovirus transfusion‐transmitted risks after universal leukoreduction. Transfusion 2010; 50: 776 ‐ 86.en_US
dc.identifier.citedreferenceVamvakas EC. Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta‐analysis. Tranfus Med Rev 2005; 19: 181 ‐ 99.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1537-2995.2012.03739.x.pdf
Size:
55.55KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.